Thursday, October 28, 2010

FT.com / Companies / Pharmaceuticals - Drugmakers face rising fines and sentences

>
via ft.com

Neil Getnick, managing partner of Getnick & Getnick, the law firm that brought the action against GSK, says: “We have a very active whistleblower practice with pending actions and cases that continue to come to us. We’re talking about something here which is a trend, not an outlier.”

Tavy Deming, a partner with Kenney & McCafferty, a Pennsylvania-based law firm that brought a whistleblower suit on behalf of Stefan Kruszewski resulting in a $540m fine against AstraZeneca relating to marketing practices, argues that such large payments are justified because “reporting fraud is a risky endeavour and a black mark on your career”.

Posted via email from Jack's posterous

No comments: